The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells
- 1 May 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 318 (2) , 354-360
- https://doi.org/10.1016/j.bbrc.2004.04.038
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Canstatin Inhibits Akt Activation and Induces Fas-dependent Apoptosis in Endothelial CellsJournal of Biological Chemistry, 2003
- Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor PropertiesJournal of Biological Chemistry, 2000
- Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor GrowthJournal of Biological Chemistry, 2000
- Macromolecular organization of basement membranesCurrent Opinion in Cell Biology, 1996
- COLLAGENS: Molecular Biology, Diseases, and Potentials for TherapyAnnual Review of Biochemistry, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Assembly of extracellular matrixCurrent Opinion in Cell Biology, 1992
- Basement membranes: molecular organization and function in development and diseaseCurrent Opinion in Cell Biology, 1989
- A Network Model for the Organization of Type IV Collagen Molecules in Basement MembranesEuropean Journal of Biochemistry, 1981
- Anti-AngiogenesisAnnals of Surgery, 1972